ELAN
Price
$12.51
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
9 days until earnings call
TEVA
Price
$18.37
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
8 days until earnings call
Ad is loading...

ELAN vs TEVA

Header iconELAN vs TEVA Comparison
Open Charts ELAN vs TEVABanner chart's image
Elanco Animal Health
Price$12.51
Change-$0.00 (-0.00%)
Volume$3.05M
CapitalizationN/A
Teva Pharmaceutical Industries
Price$18.37
Change-$0.00 (-0.00%)
Volume$3.98M
CapitalizationN/A
View a ticker or compare two or three
ELAN vs TEVA Comparison Chart
Loading...
ELAN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TEVA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ELAN vs. TEVA commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAN is a Buy and TEVA is a Buy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (ELAN: $12.51 vs. TEVA: $18.37)
Brand notoriety: ELAN and TEVA are both notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ELAN: 48% vs. TEVA: 63%
Market capitalization -- ELAN: $7.87B vs. TEVA: $15.06B
ELAN [@Pharmaceuticals: Other] is valued at $7.87B. TEVA’s [@Pharmaceuticals: Other] market capitalization is $15.06B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAN’s FA Score shows that 1 FA rating(s) are green whileTEVA’s FA Score has 2 green FA rating(s).

  • ELAN’s FA Score: 1 green, 4 red.
  • TEVA’s FA Score: 2 green, 3 red.
According to our system of comparison, TEVA is a better buy in the long-term than ELAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAN’s TA Score shows that 4 TA indicator(s) are bullish while TEVA’s TA Score has 5 bullish TA indicator(s).

  • ELAN’s TA Score: 4 bullish, 6 bearish.
  • TEVA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TEVA is a better buy in the short-term than ELAN.

Price Growth

ELAN (@Pharmaceuticals: Other) experienced а -0.87% price change this week, while TEVA (@Pharmaceuticals: Other) price change was +1.05% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +8.21%. For the same industry, the average monthly price growth was +10.22%, and the average quarterly price growth was -2.43%.

Reported Earning Dates

ELAN is expected to report earnings on Feb 19, 2025.

TEVA is expected to report earnings on Feb 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+8.21% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TEVA($15.1B) has a higher market cap than ELAN($7.87B). TEVA YTD gains are higher at: 75.958 vs. ELAN (-16.040). TEVA has higher annual earnings (EBITDA): 1.56B vs. ELAN (-224M). TEVA has more cash in the bank: 3.23B vs. ELAN (352M). ELAN has less debt than TEVA: ELAN (5.77B) vs TEVA (20.2B). TEVA has higher revenues than ELAN: TEVA (15.8B) vs ELAN (4.42B).
ELANTEVAELAN / TEVA
Capitalization7.87B15.1B52%
EBITDA-224M1.56B-14%
Gain YTD-16.04075.958-21%
P/E RatioN/A22.62-
Revenue4.42B15.8B28%
Total Cash352M3.23B11%
Total Debt5.77B20.2B29%
FUNDAMENTALS RATINGS
ELAN vs TEVA: Fundamental Ratings
ELAN
TEVA
OUTLOOK RATING
1..100
6061
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
81
Overvalued
PROFIT vs RISK RATING
1..100
10017
SMR RATING
1..100
9493
PRICE GROWTH RATING
1..100
5740
P/E GROWTH RATING
1..100
3120
SEASONALITY SCORE
1..100
3695

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TEVA's Valuation (81) in the Pharmaceuticals Generic industry is in the same range as ELAN (83) in the Agricultural Commodities Or Milling industry. This means that TEVA’s stock grew similarly to ELAN’s over the last 12 months.

TEVA's Profit vs Risk Rating (17) in the Pharmaceuticals Generic industry is significantly better than the same rating for ELAN (100) in the Agricultural Commodities Or Milling industry. This means that TEVA’s stock grew significantly faster than ELAN’s over the last 12 months.

TEVA's SMR Rating (93) in the Pharmaceuticals Generic industry is in the same range as ELAN (94) in the Agricultural Commodities Or Milling industry. This means that TEVA’s stock grew similarly to ELAN’s over the last 12 months.

TEVA's Price Growth Rating (40) in the Pharmaceuticals Generic industry is in the same range as ELAN (57) in the Agricultural Commodities Or Milling industry. This means that TEVA’s stock grew similarly to ELAN’s over the last 12 months.

TEVA's P/E Growth Rating (20) in the Pharmaceuticals Generic industry is in the same range as ELAN (31) in the Agricultural Commodities Or Milling industry. This means that TEVA’s stock grew similarly to ELAN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELANTEVA
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
66%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
69%
MACD
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 7 days ago
76%
Declines
ODDS (%)
Bearish Trend 6 days ago
72%
Bearish Trend 5 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
65%
View a ticker or compare two or three
Ad is loading...
ELAN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TEVA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

ELAN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELAN has been loosely correlated with SNDL. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAN jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAN
1D Price
Change %
ELAN100%
+0.81%
SNDL - ELAN
39%
Loosely correlated
+1.38%
TEVA - ELAN
33%
Loosely correlated
+2.63%
ACET - ELAN
33%
Poorly correlated
+2.14%
PCRX - ELAN
32%
Poorly correlated
+1.78%
TAK - ELAN
27%
Poorly correlated
+0.22%
More

TEVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TEVA has been loosely correlated with ELAN. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if TEVA jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TEVA
1D Price
Change %
TEVA100%
+2.63%
ELAN - TEVA
34%
Loosely correlated
+0.81%
PRGO - TEVA
30%
Poorly correlated
+2.71%
VTRS - TEVA
29%
Poorly correlated
+2.80%
PCRX - TEVA
28%
Poorly correlated
+1.78%
SNDL - TEVA
26%
Poorly correlated
+1.38%
More